Hide metadata

dc.contributor.authorWibetoe, Grunde
dc.contributor.authorIkdahl, Eirik
dc.contributor.authorRollefstad, Silvia
dc.contributor.authorOlsen, Inge C
dc.contributor.authorBergsmark, Kjetil
dc.contributor.authorKvien, Tore K
dc.contributor.authorSalberg, Anne
dc.contributor.authorSoldal, Dag M
dc.contributor.authorBakland, Gunnstein
dc.contributor.authorLexberg, Åse
dc.contributor.authorFevang, Bjørg-Tilde
dc.contributor.authorGulseth, Hans C
dc.contributor.authorHaugeberg, Glenn
dc.contributor.authorSemb, Anne G
dc.date.accessioned2017-07-04T05:02:30Z
dc.date.available2017-07-04T05:02:30Z
dc.date.issued2017
dc.identifier.citationArthritis Research & Therapy. 2017 Jul 03;19(1):153
dc.identifier.urihttp://hdl.handle.net/10852/55808
dc.description.abstractBackground Patients with inflammatory joint diseases (IJD) have increased risk of cardiovascular disease (CVD). Our aim was to compare CVD risk profiles in patients with IJD, including rheumatoid arthritis (RA), axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) and evaluate the future risk of CVD. Methods The prevalence and numbers of major CVD risk factors (CVD-RFs) (hypertension, elevated cholesterol, obesity, smoking, and diabetes mellitus) were estimated in patients with RA, axSpA and PsA. Relative and absolute risk of CVD according to Systematic Coronary Risk Evaluation (SCORE) was calculated. Results In total, 3791 patients were included. CVD was present in 274 patients (7.2%). Of those without established CVD; hypertension and elevated cholesterol were the most frequent CVD-RFs, occurring in 49.8% and 32.8% of patients. Patients with PsA were more often hypertensive and obese. Overall, 73.6% of patients had a minimum of one CVD-RF, which increased from 53.2% among patients aged 30 to <45 years, to 86.2% of patients aged 60 to ≤80 years. Most patients (93.5%) had low/moderate estimated risk of CVD according to SCORE. According to relative risk estimations, 35.2% and 24.7% of patients had two or three times risk or higher, respectively, compared to individuals with no CVD-RFs. Conclusions In this nationwide Norwegian project, we have shown for the first time that prevalence and numbers of CVD-RFs were relatively comparable across the three major IJD entities. Furthermore, estimated absolute CVD risk was low, but the relative risk of CVD was markedly high in patients with IJD. Our findings indicate the need for CVD risk assessment in all patients with IJD.
dc.language.isoeng
dc.relation.ispartofWibetoe, Grunde (2019) Cardiovascular disease risk in inflammatory joint disease: Conventional disease risk factors across inflammatory joint diseases and performance of risk age models in rheumatoid arthritis. Doctoral thesis http://hdl.handle.net/10852/66549
dc.relation.urihttp://hdl.handle.net/10852/66549
dc.rightsThe Author(s); licensee BioMed Central Ltd.
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleCardiovascular disease risk profiles in inflammatory joint disease entities
dc.typeJournal article
dc.date.updated2017-07-04T05:02:30Z
dc.creator.authorWibetoe, Grunde
dc.creator.authorIkdahl, Eirik
dc.creator.authorRollefstad, Silvia
dc.creator.authorOlsen, Inge C
dc.creator.authorBergsmark, Kjetil
dc.creator.authorKvien, Tore K
dc.creator.authorSalberg, Anne
dc.creator.authorSoldal, Dag M
dc.creator.authorBakland, Gunnstein
dc.creator.authorLexberg, Åse
dc.creator.authorFevang, Bjørg-Tilde
dc.creator.authorGulseth, Hans C
dc.creator.authorHaugeberg, Glenn
dc.creator.authorSemb, Anne G
dc.identifier.doihttp://dx.doi.org/10.1186/s13075-017-1358-1
dc.identifier.urnURN:NBN:no-58569
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/55808/1/13075_2017_Article_1358.pdf
dc.type.versionPublishedVersion
cristin.articleid153


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International